Page last updated: 2024-08-22

palmatine and Alzheimer Disease

palmatine has been researched along with Alzheimer Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's5 (83.33)2.80

Authors

AuthorsStudies
Andrisano, V; Cahlikova, L; Hostalkova, A; Hulcova, D; Jun, D; Korabecny, J; Kucera, T; Kunes, J; Marikova, J; Novakova, L; Opletal, L; Perez, DI; Siatka, T1
Cheng, Q; Jia, W; Luo, X; Peng, Q; Qiao, A; Su, Q; Wang, Y; Zhang, J1
Chen, W; Du, R; He, Z; Pei, H; Zeng, J1
Baykal, AT; Coskun, J; Gurel, B; Karayel-Basar, M; Kiris, I; Kukula-Koch, W1
Ge, P; Guo, R; Guo, S; Lei, S; Qi, Y; Wang, N; Wei, X; Wu, W; Xiao, Q; Yang, N; Zhang, Q; Zhao, L; Zhao, X; Zhou, P; Zhu, H1
Kim, DH; Kim, YY; Lee, DY; Lee, KM; Um, JH; Yun, J1

Other Studies

6 other study(ies) available for palmatine and Alzheimer Disease

ArticleYear
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    Journal of natural products, 2019, 02-22, Volume: 82, Issue:2

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Berberis; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Plant Exudates

2019
Neuroprotective Effects of Palmatine via the Enhancement of Antioxidant Defense and Small Heat Shock Protein Expression in A
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Berberine Alkaloids; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Heat-Shock Proteins, Small; Humans; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species

2021
Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer's disease.
    Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:11

    Topics: Alzheimer Disease; Animals; Interleukin-6; Lipopolysaccharides; Mice; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha

2022
Proteomic alterations in the cerebellum and hippocampus in an Alzheimer's disease mouse model: Alleviating effect of palmatine.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Alzheimer Disease; Animals; Cerebellum; Disease Models, Animal; Hippocampus; Mice; Mice, Transgenic; Proteomics

2023
An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine.
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Berberine; Cytokines; Exosomes; Mice; Neuroinflammatory Diseases; Plaque, Amyloid

2023
The Natural Alkaloid Palmatine Selectively Induces Mitophagy and Restores Mitochondrial Function in an Alzheimer's Disease Mouse Model.
    International journal of molecular sciences, 2023, Nov-20, Volume: 24, Issue:22

    Topics: Alkaloids; Alzheimer Disease; Animals; Humans; Mice; Mitochondria; Mitophagy; Ubiquitin-Protein Ligases

2023